• Home |
• Contact Us |
• Sitemap

• 
  • Overview
  • Management Team
  • Board of Directors
  • Scientific Advisory Board
  • Careers
    • Current Openings
    • Benefits
• 
  • About Pathogen Inactivation
    • Conventional Blood Testing
    • International Consensus Conference on Pathogen Inactivation
  • Glossary of Terms
• 
  • How INTERCEPT Works
  • Product Pipeline
  • Commercializing The INTERCEPT System
  • The INTERCEPT Blood System
  • Case Study
• 
  • Abstracts
  • Archived Abstracts
  • Publications
  • Archived Publications
• 
  • Investor Overview
  • Corporate Governance
  • Analyst Coverage
  • Press Releases
  • Investor Events
  • Webcasts
  • SEC Filings
  • Annual Reports
  • Annual Meeting
  • Stock Information
  • Ownership Summary
  • Information Request
  • Investor Contacts
  • RSS Feeds
• 
  • 2008 Archived Events

Investors

Investor Overview Corporate Governance Analyst Coverage Press Releases Investor Events Webcasts SEC Filings Annual Reports Annual Meeting Stock Information Ownership Summary Information Request Investor Contacts RSS Feeds

Analyst Coverage

Firm  Avondale Partners, LLC Robert W. Baird & Co.

Analyst Daniel Owczarski Christopher J. Raymond

Cerus Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cerus Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cerus Corporation or its management. Cerus Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

© 2010 Cerus Corporation

• Legal |
• Privacy

Powered By Q4 Web Systems 3.5.8.1201